Berlin – While working at SMP, Martin Schaper advised 1717 Life Science Ventures on the sale of its stake in drug developer PENTIXAPHARM to Eckert & Ziegler Strahlen- und Medizintechnik AG. In the course of the transaction, Eckert & Ziegler acquired a direct majority stake in PENTIXAPHARM, a joint venture between Scintomics GmbH and 1717 Life Science Ventures GmbH.
The team has already advised on the establishment of the joint venture in 2019.
With a solid history of building successful radiopharmaceutical startups, the 1717 team has personal experience in all key functions of an early-stage radiopharmaceutical development company. PENTIXAPHARM is developing a radiopharmaceutical combination product for lymphoma and a number of related tumors. Together with an internal transfer, Eckert & Ziegler says it will directly hold around 83% of the shares in the Würzburg-based company after the closing. The management of PENTIXAPHARM, which holds the remaining 17% of PENTIXAPHARM shares, also received put options on the remaining shares as part of the share sale. Further information can be found here.
Advisors 1717 Life Science Ventures GmbH:
Dr. Martin Schaper, Partner
About us
YPOG stands for You + Partners of Gamechangers. As a leading law and tax firm, YPOG supports founders, investors, companies and funds in Germany and internationally in bringing visionary ideas to life in the tech ecosystem and dynamic future markets.
YPOG advises on the structuring of venture capital and private equity funds, financing rounds and complex transactions, as well as on regulatory and tax matters relating to digital assets and financial innovation. As a strategic partner, YPOG develops practical solutions of the highest legal standard.
The firm combines legal and tax expertise with legal tech, digital workflows and AI-based systems to provide efficient and scalable advice.
YPOG and its professionals are regularly recognised by JUVE, Chambers and Partners, The Legal 500, Best Lawyers and Leaders League. More than 380 lawyers, tax advisers, tax specialists, one notary and business professionals work for YPOG across its offices in Berlin, Cologne, Hamburg and Munich.
Further information: www.ypog.law/en/ and www.linkedin.com/company/ypog
